Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (radiation therapy oncology group 9813): Implications for studies testing initial treatment of brain tumors Article

Chang, SM, Seiferheld, W, Curran, W et al. (2004). Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (radiation therapy oncology group 9813): Implications for studies testing initial treatment of brain tumors . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 59(4), 1122-1126. 10.1016/j.ijrobp.2004.01.002

International Collaboration

cited authors

  • Chang, SM; Seiferheld, W; Curran, W; Share, R; Atkins, J; Choucair, A; Kresl, J; Thoron, L; Cairncross, G; Gilbert, M; Bahary, JP; Dolinskas, C; Louis, DN; Bushunow, P; Buckner, J; Barger, G; Mehta, M

sustainable development goals

authors

publication date

  • July 15, 2004

webpage

published in

keywords

  • 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA
  • CLINICAL-TRIALS
  • CONSORTIUM
  • DESIGN
  • Life Sciences & Biomedicine
  • Oncology
  • PLUS O-6-BENZYLGUANINE
  • PROGRESSIVE MALIGNANT GLIOMA
  • RECURRENT
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology
  • XENOGRAFTS
  • anaplastic astrocytoma
  • carmustine
  • radiotherapy
  • temozolomide

Location

  • SAN DIEGO, CA

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 1122

end page

  • 1126

volume

  • 59

issue

  • 4